← Back to Search

Digital Therapeutic B for Depression (MIRAI Trial)

N/A
Waitlist Available
Research Sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from day 1 to week 6.
Awards & highlights

MIRAI Trial Summary

This trial compares two digital therapies to see if they can improve depression in adults who are already taking antidepressants.

Eligible Conditions
  • Depression

MIRAI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from day 1 to week 6.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from day 1 to week 6. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Montgomery-Asberg Depression Rating Scale (MADRS)
Secondary outcome measures
Generalized Anxiety Disorder-7 (GAD-7)

MIRAI Trial Design

2Treatment groups
Experimental Treatment
Group I: Digital Therapeutic BExperimental Treatment1 Intervention
Digital Therapeutic Version B
Group II: Digital Therapeutic AExperimental Treatment1 Intervention
Digital Therapeutic Version A
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MIRAI Depression Study Digital Therapetic
2021
N/A
~390

Find a Location

Who is running the clinical trial?

Click Therapeutics, Inc.Industry Sponsor
15 Previous Clinical Trials
2,581 Total Patients Enrolled
Otsuka Pharmaceutical Development & Commercialization, Inc.Lead Sponsor
245 Previous Clinical Trials
166,609 Total Patients Enrolled
28 Trials studying Depression
39,833 Patients Enrolled for Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder
2021. "Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04770285.
~93 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top